Literature DB >> 15331692

Herpes simplex virus type 1 regulatory protein ICP0 does not protect cyclins D1 and D3 from degradation during infection.

Roger D Everett1.   

Abstract

Previous reports have suggested that herpes simplex virus type 1 (HSV-1) immediate-early regulatory protein ICP0 stabilizes cyclins D1 and D3 during infection by inducing the degradation of cdc34, the E2-conjugating enzyme that is responsible for regulating the stability of these cyclins. Since ICP0 has complex effects on the progress of viral infection that vary greatly with cell type and viral dose, it can be difficult to distinguish between direct effects caused by ICP0 itself and indirect effects caused by the rate of the progression of infection in the absence of ICP0 at the chosen multiplicity of infection. This report describes the fates of cdc34 and cyclins D1 and D3 during HSV-1 infection under conditions that ensured that viral infection and gene expression were proceeding at equivalent rates in the presence and absence of ICP0. It was confirmed that both D-type cyclins were unstable during HSV-1 infection of a variety of cell types, but no effect on cdc34 was observed, even when high levels of ICP0 were expressed. Furthermore, there was no evidence that ICP0 protected either cyclin D1 or cyclin D3 from degradation. Reconstruction of the conditions of the experiments in the previous studies, using the stated cell type and multiplicities of infection, indicated that the original results could be explained by differences in the rate of progression of infection rather than by the presence or absence of ICP0. The data presented in this report are incompatible with the hypothesis that ICP0 induces the degradation of cdc34 and thereby stabilizes cyclins D1 and D3 during HSV-1 infection. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331692      PMCID: PMC514960          DOI: 10.1128/JVI.78.18.9599-9604.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

Review 1.  Repression of viral transcription during herpes simplex virus latency.

Authors:  C M Preston
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

Review 2.  ICP0, a regulator of herpes simplex virus during lytic and latent infection.

Authors:  R D Everett
Journal:  Bioessays       Date:  2000-08       Impact factor: 4.345

3.  The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.

Authors:  C Van Sant; R Hagglund; P Lopez; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes.

Authors:  Ryan Hagglund; Charles Van Sant; Pascal Lopez; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  A single amino acid substitution in the cyclin D binding domain of the infected cell protein no. 0 abrogates the neuroinvasiveness of herpes simplex virus without affecting its ability to replicate.

Authors:  C Van Sant; Y Kawaguchi; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

6.  Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.

Authors:  G L Ehmann; T I McLean; S L Bachenheimer
Journal:  Virology       Date:  2000-02-15       Impact factor: 3.616

7.  The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.

Authors:  Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-10       Impact factor: 11.205

8.  Role of cyclin D3 in the biology of herpes simplex virus 1 ICPO.

Authors:  C Van Sant; P Lopez; S J Advani; B Roizman
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0.

Authors:  Roger D Everett; Chris Boutell; Anne Orr
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more
  9 in total

1.  Cellular Protein WDR11 Interacts with Specific Herpes Simplex Virus Proteins at the trans-Golgi Network To Promote Virus Replication.

Authors:  Kathryne E Taylor; Karen L Mossman
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

2.  Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).

Authors:  Emilia Vanni; Derek Gatherer; Lily Tong; Roger D Everett; Chris Boutell
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

3.  Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7.

Authors:  Chris Boutell; Mary Canning; Anne Orr; Roger D Everett
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  HSV-1 ICP0: paving the way for viral replication.

Authors:  Miles C Smith; Chris Boutell; David J Davido
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

5.  Widely Used Herpes Simplex Virus 1 ICP0 Deletion Mutant Strain dl1403 and Its Derivative Viruses Do Not Express Glycoprotein C Due to a Secondary Mutation in the gC Gene.

Authors:  Cristina W Cunha; Kathryne E Taylor; Suzanne M Pritchard; Mark G Delboy; Tri Komala Sari; Hector C Aguilar; Karen L Mossman; Anthony V Nicola
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

6.  HSV-1 ICP0: An E3 Ubiquitin Ligase That Counteracts Host Intrinsic and Innate Immunity.

Authors:  Mirna Perusina Lanfranca; Heba H Mostafa; David J Davido
Journal:  Cells       Date:  2014-05-20       Impact factor: 6.600

7.  Timing Is Everything.

Authors:  Luis M Schang
Journal:  MBio       Date:  2018-01-02       Impact factor: 7.867

8.  The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection.

Authors:  Delphine Cuchet-Lourenço; Gail Anderson; Elizabeth Sloan; Anne Orr; Roger D Everett
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

9.  Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus.

Authors:  Bonnie Reinhart; Lucia Mazzacurati; Adriana Forero; Chang-Sook Hong; Junichi Eguchi; Hideho Okada; Wendy Fellows; Ajay Niranjan; Justus B Cohen; Joseph C Glorioso; Paola Grandi
Journal:  Adv Virol       Date:  2012-08-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.